Knowledge of Clinical Trials Among US Cancer Survivors: Cross-Sectional Study of HINTS-SEER Data
JMIR Cancer · 2025
DOI: 10.2196/76187 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift JMIR Cancer, 2025. Verfasst von Aisha Tene Langford und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Family Medicine and Public Health Sciences, Wayne State University, 6135 Woodward Ave, Detroit, MI, 48111, United States, 1 3135775644. Hauptthemen laut MEDLINE: Cancer Survivors, Neoplasms, Clinical Trials as Topic, Health Knowledge, Attitudes, Practice. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Clinical trials are important for all stages of the cancer control continuum, including cancer survivorship.
Objective
The purpose of this study was to evaluate correlates of general clinical trial knowledge among US adult cancer survivors.
Methods
We conducted a cross-sectional analysis of the National Cancer Institute’s 2021 Health Information National Trends Survey. Cancer survivors were recruited from 3 Surveillance, Epidemiology, and End Results registries: Iowa Cancer Registry, Greater Bay Area Cancer Registry, and New Mexico Tumor Registry. Data collection occurred from January 11 to August 20, 2021. Eligible participants had a cancer diagnosis prior to 2018. The primary outcome was self-reported knowledge of clinical trials, assessed by the question: “ How would you describe your level of knowledge about clinical trials? ” Responses were dichotomized as knowing “a lot” or “a little bit” versus “don’t know anything.” Independent variables included sociodemographic characteristics, patient-centered communication, health information seeking (including watching health-related videos on YouTube), and confidence in obtaining cancer-related information. We used survey-weighted logistic regression to examine univariable and multivariable associations with clinical trial knowledge. A total of 2 a priori hypotheses were specified: (1) cancer survivors with a higher perceived quality of patient-centered communication would have greater knowledge of clinical trials than those with a lower perceived quality of patient-centered communication and (2) cancer survivors who were “completely confident” in their ability to obtain cancer-related information would have greater knowledge of clinical trials than those less confident. Odds ratios (ORs), 95% CIs, and P values were estimated using SAS (version 9.4; SAS Institute Inc, Cary, NC, USA).
Results
Among cancer survivors (N=1207) included in the analysis, 269 (22.3%) reported that they did not know anything about clinical trials, while 938 (77.7%) reported knowing “a lot” or “a little.” Neither of the 2 a priori hypotheses was supported. In the multivariable weighted logistic regression model, greater knowledge of clinical trials was significantly associated with non-Hispanic White race compared with all other races (OR 2.55, 95% CI 1.59, 4.08; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Family Medicine and Public Health Sciences, Wayne State University, 6135 Woodward Ave, Detroit, MI, 48111, United States, 1 3135775644.
- University of Michigan, Ann Arbor, MI, United States.
- Nancy Buderer Consulting, LLC, Oak Harbor, OH, United States.
ORCID-Profile: Aisha Tene Langford, Katrina Renee Ellis, Nancy Buderer, Navreet Singh
Zitieren
APA
Langford, A. T., Ellis, K. R., Buderer, N., & Singh, N. (2025). Knowledge of Clinical Trials Among US Cancer Survivors: Cross-Sectional Study of HINTS-SEER Data. JMIR Cancer. https://doi.org/10.2196/76187
Vancouver
Langford AT, Ellis KR, Buderer N, Singh N. Knowledge of Clinical Trials Among US Cancer Survivors: Cross-Sectional Study of HINTS-SEER Data. JMIR Cancer. 2025. doi:10.2196/76187
BibTeX
@article{Langford2025,
author = {Langford, Aisha Tene and Ellis, Katrina Renee and Buderer, Nancy and Singh, Navreet},
title = {Knowledge of Clinical Trials Among US Cancer Survivors: Cross-Sectional Study of HINTS-SEER Data},
journal = {JMIR Cancer},
year = {2025},
doi = {10.2196/76187}
}
EUVIMED